Indications for and outcomes of therapeutic plasma exchange after cardiac transplantation: A single center retrospective study.

Published

Journal Article

INTRODUCTION:Limited data are available describing indications for and outcomes of therapeutic plasma exchange (TPE) in cardiac transplantation. METHODS:In a retrospective study of patients who underwent cardiac transplantation at Duke University Medical Center from 2010 to 2014, we reviewed 3 TPE treatment patterns: a Single TPE procedure within 24 h of transplant; Multiple TPE procedures initiated within 24 h of transplant; and 1 or more TPE procedures beginning >24 h post-transplant. Primary and secondary outcomes were overall survival (OS) and TPE survival (TS), respectively. RESULTS:Of 313 patients meeting study criteria, 109 (35%) underwent TPE. TPE was initiated in 82 patients within 24 h, 40 (37%) receiving a single procedure (Single TPE), and 42 (38%) multiple procedures (Multiple TPE). Twenty-seven (25%) began TPE >24 h after transplant (Delayed TPE). The most common TPE indication was elevated/positive panel reactive or human leukocyte antigen antibodies (32%). With a median follow-up of 49 months, the non-TPE treated and Single TPE cohorts had similar OS (HR 1.08 [CI, 0.54, 2.14], P = .84), while the Multiple and Delayed TPE cohorts had worse OS (HR 2.62 [CI, 1.53, 4.49] and HR 1.98 [CI, 1.02, 3.83], respectively). The Multiple and Delayed TPE cohorts also had worse TS (HR 2.59 [CI, 1.31, 5.14] and HR 3.18 [CI, 1.56, 6.50], respectively). Infection rates did not differ between groups but was independently associated with OS (HR 2.31 [CI, 1.50, 3.54]). CONCLUSIONS:TPE is an important therapeutic modality in cardiac transplant patients. Prospective studies are needed to better define TPE's different roles in this patient population.

Full Text

Duke Authors

Cited Authors

  • Onwuemene, OA; Grambow, SC; Patel, CB; Mentz, RJ; Milano, CA; Rogers, JG; Metjian, AD; Arepally, GM; Ortel, TL

Published Date

  • August 2018

Published In

Volume / Issue

  • 33 / 4

Start / End Page

  • 469 - 479

PubMed ID

  • 29524240

Pubmed Central ID

  • 29524240

Electronic International Standard Serial Number (EISSN)

  • 1098-1101

International Standard Serial Number (ISSN)

  • 0733-2459

Digital Object Identifier (DOI)

  • 10.1002/jca.21622

Language

  • eng